✦ LIBER ✦

Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: A clinical Phase II trial

✍ Scribed by Gui-Yuan Chen; Guo-Liang Jiang; Li-Juan Wang; Hao Qian; Xiao-Long Fu; Huajun Yang; Kai-Liang Wu; Sen Zhao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A preliminary report: Concurrent twice-d

✍ Andrew T. Turrisi III; Donna J. Glover; Bernard A. Mason 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 569 KB

Phase II trial of combination chemothera

✍ Yoichi Nakanishi; Yuji Kawarada; Nobuyuki Hirose; Kiyoshi Ninomiya; Masayuki Miy 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 340 KB

Phase II trial of combined radiotherapy

✍ Gerrit Van Harskamp; Epie Boven; Jan B. Vermorken; Henk Van Deutekom; Jaap Stam; 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 527 KB

70 Gy thoracic radiotherapy (TRT) is fea

✍ J.A Bogart; J.E Herndon; A.P Lyss; D Watson; A.A Miller; M.E Lee; A.T Turrisi; M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 19 KB

Phase II trial of S-1 and cisplatin with

✍ Ohyanagi, F; Yamamoto, N; Horiike, A; Harada, H; Kozuka, T; Murakami, H; Gomi, K 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

Daily (D) vs. twice-daily (BID) thoracic

✍ H. Wagner; K. Kim; D.H. Johnson; R. Komaki; W. Sause; W. Curran; R. Livingston; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 144 KB